TheProfitWatch

GLMD - Galmed Pharmaceuticals Ltd.

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.44 0.07 (4.69%) --- --- --- -0.01 (-0.69%) 0.05 (3.55%) 0.08 (5.42%) 0.08 (5.42%)

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.

Category: /stock/categories/na
Market Period: Closed

Earnings & Ratios

Basic EPS:
Diluted EPS:
Basic P/E:
Diluted P/E:
RSI(14) 1m:
100.0
VWAP:
1.51
RVol:
0.4871

Events

Period Kind Movement Occurred At
60m Price increase 60m 1.51 +0.08 (+5.42%) Oct 15 18:36

Related News